Approaching Inflammation Paradoxes—Proinflammatory Cytokine Blockages Induce Inflammatory Regulators
Genre
Journal articleDate
2020-10-19Author
Liu, MingSaredy, Jason
Zhang, Ruijing
Shao, Ying
Sun, Yu
Yang, William Y.
Wang, Jirong
Liu, Lu
Drummer, Charles
Johnson, Candice
Saaoud, Fatma
Lu, Yifan
Xu, Keman
Li, Li
Wang, Xin
Jiang, Xiaohua
Wang, Hong

Yang, Xiaofeng
Group
Center for Cardiovascular Research (Temple University)Center for Inflammation, Translational & Clinical Lung Research (Temple University)
Center for Metabolic Disease Research (Temple University)
Center for Cardiovascular Research (Temple University)
Center for Thrombosis Research (Temple University)
Department
PharmacologyMicrobiology
Immunology
Subject
Proinflammatory cytokine blockageProinflammatory cytokines
Inflammation
Innate immune regulators
Reactive oxygen species
Permanent link to this record
http://hdl.handle.net/20.500.12613/4171
Metadata
Show full item recordDOI
http://doi.org/10.3389/fimmu.2020.554301Abstract
The mechanisms that underlie various inflammation paradoxes, metabolically healthy obesity, and increased inflammations after inflammatory cytokine blockades and deficiencies remain poorly determined. We performed an extensive –omics database mining, determined the expressions of 1367 innate immune regulators in 18 microarrays after deficiencies of 15 proinflammatory cytokines/regulators and eight microarray datasets of patients receiving Mab therapies, and made a set of significant findings: 1) proinflammatory cytokines/regulators suppress the expressions of innate immune regulators; 2) upregulations of innate immune regulators in the deficiencies of IFNγ/IFNγR1, IL-17A, STAT3 and miR155 are more than that after deficiencies of TNFα, IL-1β, IL-6, IL-18, STAT1, NF-kB, and miR221; 3) IFNγ, IFNγR and IL-17RA inhibit 10, 59 and 39 proinflammatory cytokine/regulator pathways, respectively; in contrast, TNFα, IL-6 and IL-18 each inhibits only four to five pathways; 4) The IFNγ-promoted and -suppressed innate immune regulators have four shared pathways; the IFNγR1-promoted and -suppressed innate immune regulators have 11 shared pathways; and the miR155-promoted and -suppressed innate immune regulators have 13 shared pathways, suggesting negative-feedback mechanisms in their conserved regulatory pathways for innate immune regulators; 5) Deficiencies of proinflammatory cytokine/regulator-suppressed, promoted programs share signaling pathways and increase the likelihood of developing 11 diseases including cardiovascular disease; 6) There are the shared innate immune regulators and pathways between deficiency of TNFα in mice and anti-TNF therapy in clinical patients; 7) Mechanistically, up-regulated reactive oxygen species regulators such as myeloperoxidase caused by suppression of proinflammatory cytokines/regulators can drive the upregulation of suppressed innate immune regulators. Our findings have provided novel insights on various inflammation paradoxes and proinflammatory cytokines regulation of innate immune regulators; and may re-shape new therapeutic strategies for cardiovascular disease and other inflammatory diseases.Citation
Liu M, Saredy J, Zhang R, Shao Y, Sun Y, Yang WY, Wang J, Liu L, Drummer C IV, Johnson C, Saaoud F, Lu Y, Xu K, Li L, Wang X, Jiang X, Wang H and Yang X (2020) Approaching Inflammation Paradoxes—Proinflammatory Cytokine Blockages Induce Inflammatory Regulators. Front. Immunol. 11:554301. doi: 10.3389/fimmu.2020.554301Citation to related work
FrontiersHas part
Frontiers in Immunology, Vol. 11ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/4153